批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
| 审批日期 | 提交号 | 审批结论 | 提交分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2014/08/22 |
ORIG-1(原始申请) |
Approval |
|
|
|
|
>>>补充申请<<<
| 审批日期 | 提交号 | 审批结论 | 补充类别或审批类型 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2019/07/23 |
SUPPL-11(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2019/07/23 |
SUPPL-4(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2015/11/17 |
SUPPL-1(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
| 关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
| 无 |
与本品治疗等效的药品
>>>活性成分:RIVASTIGMINE TARTRATE; 剂型/给药途径:CAPSULE;ORAL; 规格:EQ 1.5MG BASE; 治疗等效代码:AB<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 077131 |
001 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 1.5MG BASE |
Discontinued |
No |
No |
AB |
2007/10/22
|
SUN PHARM |
| 077130 |
001 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 1.5MG BASE |
Prescription |
No |
Yes |
AB |
2007/10/31
|
DR REDDYS LABS INC |
| 077129 |
001 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 1.5MG BASE |
Prescription |
No |
No |
AB |
2008/01/08
|
WATSON LABS |
| 091689 |
001 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 1.5MG BASE |
Prescription |
No |
No |
AB |
2012/06/12
|
ALEMBIC PHARMS LTD |
| 203148 |
001 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 1.5MG BASE |
Prescription |
No |
No |
AB |
2014/08/22
|
MACLEODS PHARMS LTD |
| 090879 |
001 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 1.5MG BASE |
Prescription |
No |
No |
AB |
2015/06/10
|
ORBION PHARMS |
| 204572 |
001 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 1.5MG BASE |
Prescription |
No |
No |
AB |
2016/03/25
|
AUROBINDO PHARMA |
| 203844 |
001 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 1.5MG BASE |
Prescription |
No |
No |
AB |
2017/02/13
|
CADILA PHARMS LTD |
| 207797 |
001 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 1.5MG BASE |
Prescription |
No |
No |
AB |
2017/09/28
|
CHARTWELL RX |
>>>活性成分:RIVASTIGMINE TARTRATE; 剂型/给药途径:CAPSULE;ORAL; 规格:EQ 3MG BASE; 治疗等效代码:AB<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 077131 |
002 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 3MG BASE |
Discontinued |
No |
No |
AB |
2007/10/22
|
SUN PHARM |
| 077130 |
002 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 3MG BASE |
Prescription |
No |
No |
AB |
2007/10/31
|
DR REDDYS LABS INC |
| 077129 |
002 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 3MG BASE |
Prescription |
No |
No |
AB |
2008/01/08
|
WATSON LABS |
| 091689 |
002 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 3MG BASE |
Prescription |
No |
No |
AB |
2012/06/12
|
ALEMBIC PHARMS LTD |
| 203148 |
002 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 3MG BASE |
Prescription |
No |
No |
AB |
2014/08/22
|
MACLEODS PHARMS LTD |
| 090879 |
002 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 3MG BASE |
Prescription |
No |
No |
AB |
2015/06/10
|
ORBION PHARMS |
| 204572 |
002 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 3MG BASE |
Prescription |
No |
No |
AB |
2016/03/25
|
AUROBINDO PHARMA |
| 203844 |
002 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 3MG BASE |
Prescription |
No |
No |
AB |
2017/02/13
|
CADILA PHARMS LTD |
| 207797 |
002 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 3MG BASE |
Prescription |
No |
No |
AB |
2017/09/28
|
CHARTWELL RX |
>>>活性成分:RIVASTIGMINE TARTRATE; 剂型/给药途径:CAPSULE;ORAL; 规格:EQ 4.5MG BASE; 治疗等效代码:AB<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 077131 |
003 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 4.5MG BASE |
Discontinued |
No |
No |
AB |
2007/10/22
|
SUN PHARM |
| 077130 |
003 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 4.5MG BASE |
Prescription |
No |
No |
AB |
2007/10/31
|
DR REDDYS LABS INC |
| 077129 |
003 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 4.5MG BASE |
Prescription |
No |
No |
AB |
2008/01/08
|
WATSON LABS |
| 091689 |
003 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 4.5MG BASE |
Prescription |
No |
No |
AB |
2012/06/12
|
ALEMBIC PHARMS LTD |
| 203148 |
003 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 4.5MG BASE |
Prescription |
No |
No |
AB |
2014/08/22
|
MACLEODS PHARMS LTD |
| 090879 |
003 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 4.5MG BASE |
Prescription |
No |
No |
AB |
2015/06/10
|
ORBION PHARMS |
| 204572 |
003 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 4.5MG BASE |
Prescription |
No |
No |
AB |
2016/03/25
|
AUROBINDO PHARMA |
| 203844 |
003 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 4.5MG BASE |
Prescription |
No |
No |
AB |
2017/02/13
|
CADILA PHARMS LTD |
| 207797 |
003 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 4.5MG BASE |
Prescription |
No |
No |
AB |
2017/09/28
|
CHARTWELL RX |
>>>活性成分:RIVASTIGMINE TARTRATE; 剂型/给药途径:CAPSULE;ORAL; 规格:EQ 6MG BASE; 治疗等效代码:AB<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 077131 |
004 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 6MG BASE |
Discontinued |
No |
No |
AB |
2007/10/22
|
SUN PHARM |
| 077130 |
004 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 6MG BASE |
Prescription |
No |
Yes |
AB |
2007/10/31
|
DR REDDYS LABS INC |
| 077129 |
004 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 6MG BASE |
Prescription |
No |
No |
AB |
2008/01/08
|
WATSON LABS |
| 091689 |
004 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 6MG BASE |
Prescription |
No |
No |
AB |
2012/06/12
|
ALEMBIC PHARMS LTD |
| 203148 |
004 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 6MG BASE |
Prescription |
No |
No |
AB |
2014/08/22
|
MACLEODS PHARMS LTD |
| 090879 |
004 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 6MG BASE |
Prescription |
No |
No |
AB |
2015/06/10
|
ORBION PHARMS |
| 204572 |
004 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 6MG BASE |
Prescription |
No |
No |
AB |
2016/03/25
|
AUROBINDO PHARMA |
| 203844 |
004 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 6MG BASE |
Prescription |
No |
No |
AB |
2017/02/13
|
CADILA PHARMS LTD |
| 207797 |
004 |
ANDA |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE;ORAL |
EQ 6MG BASE |
Prescription |
No |
No |
AB |
2017/09/28
|
CHARTWELL RX |